H5N1 claims first African victim:
This article was originally published in Clinica
Executive Summary
The Egyptian ministry of health yesterday confirmed the country's first case of human infection with the H5N1 virus, making it also the first avian flu death in Africa. The patient, a 30-year-old woman from the Qaliubiya governorate, near Cairo, developed symptoms in early March and died within 24 hours of being hospitalised. Testing was conducted by the Cairo-based US Naval Medical Research Unit, NAMRU-3. Diagnostic verification and further analysis is being conducted by a WHO collaborating laboratory. The news follows World Health Organization warnings to health authorities across the continent to rapidly develop surveillance systems and healthcare services.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.